insiderlens
.
insiderlens
.
Transactions
Rechercher
Se connecter
InsiderLens
Market
›
Sector
›
Issuer
›
Insider
RA Capital Nexus Fund III, L.P.
›
Filing
US
Entité déclarante
RA Capital Nexus Fund III, L.P.
.
Transactions récentes
Transactions totales
24
Entreprises
3
Achats / Ventes
5
/
8
Dernière transaction
28 oct. 2025
24 oct. 2025
SALE
Sionna Therapeutics, Inc.
66 672
39.50 USD
indirect
· See footnotes
24 oct. 2025
SALE
Sionna Therapeutics, Inc.
122 271
39.50 USD
indirect
· See footnotes
28 oct. 2025
SALE
Sionna Therapeutics, Inc.
3 624
39.58 USD
indirect
· See footnotes
28 oct. 2025
SALE
Sionna Therapeutics, Inc.
10 476
39.58 USD
indirect
· See footnotes
28 oct. 2025
SALE
Sionna Therapeutics, Inc.
17 118
39.58 USD
indirect
· See footnotes
24 oct. 2025
SALE
Sionna Therapeutics, Inc.
107 941
39.50 USD
indirect
· See footnotes
28 oct. 2025
SALE
Sionna Therapeutics, Inc.
31 392
39.58 USD
indirect
· See footnotes
24 oct. 2025
SALE
Sionna Therapeutics, Inc.
14 116
39.50 USD
indirect
· See footnotes
09 juin 2025
GRANT_AWARD
Bicara Therapeutics Inc.
23 746
0.00 USD
indirect
· See Footnotes
deriv
13 mars 2025
PURCHASE
Mineralys Therapeutics, Inc.
1 296 296
13.50 USD
indirect
· See footnotes
16 sept. 2024
CONVERSION
Bicara Therapeutics Inc.
2 500 095
—
indirect
· See footnotes
16 sept. 2024
PURCHASE
Bicara Therapeutics Inc.
1 680 520
18.00 USD
indirect
· See footnotes
16 sept. 2024
PURCHASE
Bicara Therapeutics Inc.
152 480
18.00 USD
indirect
· See footnotes
16 sept. 2024
CONVERSION
Bicara Therapeutics Inc.
2 622 898
—
indirect
· See footnotes
16 sept. 2024
CONVERSION
Bicara Therapeutics Inc.
18 409 755
—
indirect
· See Footnotes
deriv
16 sept. 2024
CONVERSION
Bicara Therapeutics Inc.
12 273 169
—
indirect
· See Footnotes
deriv
16 sept. 2024
CONVERSION
Bicara Therapeutics Inc.
5 835 024
—
indirect
· See Footnotes
deriv
16 sept. 2024
CONVERSION
Bicara Therapeutics Inc.
10 836 474
—
indirect
· See Footnotes
deriv
14 févr. 2023
PURCHASE
Mineralys Therapeutics, Inc.
131 600
16.00 USD
indirect
· See footnotes
14 févr. 2023
CONVERSION
Mineralys Therapeutics, Inc.
1 735 629
—
indirect
· See footnotes
14 févr. 2023
CONVERSION
Mineralys Therapeutics, Inc.
192 847
—
indirect
· See footnotes
14 févr. 2023
PURCHASE
Mineralys Therapeutics, Inc.
1 118 400
16.00 USD
indirect
· See footnotes
14 févr. 2023
CONVERSION
Mineralys Therapeutics, Inc.
192 847
0.00 USD
indirect
· See footnotes
deriv
14 févr. 2023
CONVERSION
Mineralys Therapeutics, Inc.
1 735 629
0.00 USD
indirect
· See footnotes
deriv